Source control is a cornerstone of managing infections and sepsis in the intensive care unit, requiring rapid recognition of infection, targeted diagnostic evaluation, and timely procedural or surgical intervention. This article presents a systems-based approach to identifying infection sources in critically ill patients through clinical assessment, targeted imaging, laboratory testing, and multidisciplinary collaboration. It outlines indications for conservative versus operative management across multiple organ systems. Emphasis is placed on early detection, anatomically focused intervention, prompt drainage of closed-space infections, judicious antibiotic use, and the role of coordinated care among intensivists, surgeons and proceduralists, and infectious disease specialists to optimize outcomes.
Key points
-
•
Early recognition of infection in the intensive care unit (ICU) relies on clinical signs and symptoms, laboratory evaluation, and a thorough physical examination.
-
•
ICU patients are prone to atypical infection presentations; maintaining a broad differential diagnosis is essential to avoid delays in obtaining source control.
-
•
Imaging selection depends on the suspected source, with computed tomography serving as the primary modality for evaluating intrathoracic and intra-abdominal infections.
-
•
Timely and adequate source control is critical; drainage or surgical intervention should not be delayed when a closed-space infection is suspected.
-
•
Multidisciplinary involvement (surgery/interventional radiology, infectious disease, and critical care) improves diagnostic accuracy and patient outcomes.
Abbreviations
| CAUTI | catheter-associated urinary tract infection |
| CLABSI | central line-associated bloodstream infection |
| CNS | central nervous system |
| CSF | cerebrospinal fluid |
| CT | computed tomography |
| ENT | ear, nose, and throat |
| HIDA | hepatobiliary iminodiacetic acid |
| I&D | incision and drainage |
| ICU | intensive care unit |
| IR | interventional radiology |
| IV | intravenous |
| NSTIs | necrotizing soft tissue infections |
| SSIs | surgical site infections |
| VATS | video-assisted thoracoscopic surgery |
| WBC | white blood cell |
Introduction
Infection and sepsis are major concerns in the intensive care unit (ICU). When signs of infection appear, clinicians should immediately consider two priorities: appropriate antibiotic coverage and source control. Source control varies depending on the patient’s surgical and medical history, anticoagulation status, and access to the affected area. The Latin phrase “Ubi pus, ibi evacua” (“where there is pus, evacuate it”) remains a guiding principle, even as medical techniques evolve. This article explores key concepts and strategies for achieving source control across various clinical scenarios.
Recognizing the need for source control
Patients may present with infections that are either community-acquired or nosocomial. Clinical signs suggesting infection include persistent fever, unexplained tachycardia, hypotension, tachypnea, or altered mental status. Less common but notable indicators include new-onset atrial fibrillation, profound thrombocytosis, or feeding intolerance, the latter of which may signal intra-abdominal infection.
A thorough physical examination is essential. This includes full skin inspection and palpation, with attention to surgical wounds, drain sites, intravenous (IV) sites, and veins for thrombophlebitis. A rectal examination may reveal perirectal abscesses or decubitus ulcers. Lung auscultation helps identify pneumonia, and abdominal palpation may uncover an intra-abdominal source. Hernia examinations can detect bowel strangulation, and oropharyngeal examinations may reveal sinusitis or poor dentition as infection sources.
Laboratory studies support clinical diagnosis. In addition to routine bloodwork, targeted laboratories offer diagnostic clues. An arterial blood gas (ABG) may be useful in intubated patients, where a declining PaO 2 /FiO 2 ratio suggests pneumonia or worsening pulmonary status. Concerning laboratory findings include leukocytosis or a sharp drop in white blood cell (WBC) count, elevated C reactive protein (CRP) and procalcitonin (though nonspecific), thrombocytosis or thrombocytopenia, and abnormal glucose levels—especially uncontrolled hyperglycemia. These findings, interpreted in clinical context, may indicate a new infection.
Maintaining a broad differential is critical. Noninfectious causes to consider include drug-induced fever, withdrawal syndromes (eg, alcohol, benzodiazepines, and opioids), transfusion reactions, seizures, venous thromboembolism, neurostorming in traumatic brain injury (TBI), spontaneous bacterial peritonitis (SBP), endocrinopathies (eg, thyroid storm and adrenal insufficiency), and postsurgical inflammation. While a prompt infectious workup is warranted, noninfectious etiologies must be considered until excluded by clinical evaluation and testing.
Diagnostic imaging workup
Once clinical suspicion for infection is raised—typically prompted by physical examination findings with or without concomitant laboratory abnormalities—the next step in the diagnostic evaluation often involves obtaining imaging studies. The choice of study depends on the clinical context and the suspected infectious source. Imaging may range from a targeted, point-of-care ultrasound of a specific anatomic region to a comprehensive near whole-body computed tomography (CT) or MRI aimed at identifying occult infection when the etiology remains uncertain.
Targeted ultrasound is commonly utilized. In emergency medicine settings, point-of-care ultrasound in the hands of trained providers can provide rapid, real-time diagnostic information in acutely unstable patients. Similarly, in the ICU, ultrasound can provide bedside diagnostics in patients who are too unstable to be moved. However, ultrasound is operator-dependent, with image quality and diagnostic yield varying based on technical skill and patient factors.
CT is a cornerstone imaging modality and is the preferred technique for assessing infectious processes in the chest, abdomen, and pelvis. When renal function allows, CT of the abdomen and pelvis with IV contrast is preferred, as it enhances visualization of bowel anatomy, vascular structures, and possible abscesses. CT can rapidly and reliably diagnose conditions such as pneumoperitoneum, perforated viscus, colitis, pancreatitis, cholecystitis, and deep space infectious—each of which may necessitate urgent source control interventions.
MRI is a less frequently utilized, but highly valuable modality that is particularly useful when detailed soft-tissue characterization is required. MRI is best at assessing the central nervous system—including the brain and spinal cord—as well as joints and, to a lesser degree, soft tissue infections.
Tagged WBC scans are nuclear medicine studies that utilize radiolabeled leukocytes to localize sites of active inflammation or infection. This modality is particularly useful in evaluating suspected osteomyelitis, prosthetic valve endocarditis, inflammatory bowel disease, and select bone marrow disorders.
Hepatobiliary iminodiacetic acid (HIDA) scans offer functional assessment of the biliary system. HIDA scans are valuable in diagnosing cholecystitis, with acalculous cholecystitis being a notable concern in ICU patients.
PET scans , often combined with CT (PET/CT), provide metabolic imaging based on radiotracer uptake in hypermetabolic tissues. Although less frequently used in acute ICU settings, PET imaging can be useful in evaluating fevers of unknown origin, hardware-associated infections, deep tissue or joint infections, and select central nervous system infections.
These imaging modalities ( Table 1 ) may all be employed to make or confirm the infectious diagnosis and guide future management. The decision to pursue follow-up imaging is individualized and requires thoughtful multidisciplinary collaboration among the intensivist, infectious disease specialist, and proceduralist/surgeon, when applicable.
Table 1
Diagnostic imaging modalities in intensive care unit infectious workup
| Modality | Primary Use Cases | Advantages | Limitations |
|---|---|---|---|
| X-ray (radiograph) | Initial evaluation of chest (pneumonia and effusion), abdomen (free air and ileus), and bones | Widely available, fast, and low cost | Limited sensitivity and specificity, poor soft tissue resolution |
| Targeted ultrasound | Gallbladder pathology, soft tissue infections, and bedside drainage (abscesses, thoracentesis, and paracentesis) | No radiation, bedside-capable, and dynamic imaging | Operator-dependent, limited by body habitus and bowel gas, variable off-hour access for formal studies |
| CT | Chest (pneumonia and empyema) and abdomen/pelvis (surgical site and deep space infections, abscesses, perforated viscus, colitis, pancreatitis, and cholecystitis) | High-resolution, rapid, widely available, excellent anatomic detail | Radiation exposure, contrast limitations (renal function and allergy), not portable |
| MRI | Central nervous system (CNS) infections (brain and spine), joints, and soft tissue infections | No radiation, superior soft tissue contrast | Longer scan time, claustrophobia, motion sensitivity, and limited availability in acute settings |
| Tagged WBC scan | Osteomyelitis, prosthetic valve infections, inflammatory bowel disease, and bone marrow disorders | Functional imaging of inflammation, useful when CT/MRI inconclusive | Time-intensive, limited spatial resolution, and less accessible |
| HIDA scan | Cholecystitis and bile leak | Functional biliary assessment, detects cystic duct obstruction | Requires radiotracer, slower, and limited use outside of hepatobiliary evaluation |
| PET scan (PET/CT) | Fever of unknown origin, hardware infections, deep tissue/joint infections, and CNS infections | Detects occult/multifocal infections | Expensive, limited availability, and not ideal for unstable patients |
Timing and adequacy of source control
Once an infection is identified, timely source control is critical to successful treatment. Closed-space infections must be drained or managed promptly, as “pus under pressure” can cause bacterial translocation, bacteremia, sepsis, and septic shock. Ideally, if surgical or interventional drainage can be completed within hours, sampling the suspected source before starting antibiotics helps identify the correct pathogen. This may not always be possible, but there are often temporizing methods that relieve acute infection, allowing for definitive control later. These include drain placement or open drainage.
A multidisciplinary approach is key to managing serious infections in critically ill patients. Early involvement of surgical expertise, infectious disease consultants, and aggressive resuscitation by the emergency department or ICU team is essential. Frequent, open communication is vital, especially when the diagnosis is unclear and collaborative problem-solving is needed.
Common intensive care unit infection sources and source control strategies
After identifying clinical signs and selecting appropriate imaging, clinicians must evaluate common ICU infections by anatomic region. This section outlines ( Table 2 ) which infections can be managed with antibiotics alone and which require procedural or surgical source control.
Table 2
Summary of source control considerations
| Central Nervous System | |
| Meningitis/encephalitis | No surgical source control; CSF sampling and removal of foreign bodies (drains) are critical |
| Intracranial abscesses/subdural empyemas | Neurosurgical stereotactic aspiration, burr hole drainage, or craniotomy depending on severity |
| Intrathoracic | |
| Pneumonia | Empiric antibiotics until culture results available; bronchoscopy aids secretion clearance but not true source control |
| Parapneumonic effusions/empyema | Thoracentesis, tube thoracostomy, and intrapleural fibrinolytics; VATS or thoracotomy with decortication for persistent or severe cases |
| Intra-abdominal | |
| Peritonitis/perforated viscus | Urgent diagnostic laparoscopy/laparotomy to identify and treat underlying cause; damage control surgery if unstable |
| Ischemic bowel | Laparotomy with bowel resection; possible temporary closure and second-look surgery; vascular intervention, if needed |
| C . difficile and toxic megacolon | Total abdominal colectomy with end ileostomy; anterograde colonic lavage via loop ileostomy as alternative to colectomy |
| Complicated biliary infections | ERCP for decompression with possible common bile duct stenting; surgical/open CBD decompression if ERCP fails |
| Cholecystitis | If stable, laparoscopic or robotic cholecystectomy; If unstable, percutaneous cholecystostomy tube placement |
| Acute pancreatitis | Step-up approach; endoscopic cystogastrostomy for pseudocyst; abdominal decompression for abdominal compartment syndrome |
| Anastomotic leaks and postoperative deep space infections | IR drainage preferred over open surgery; re-entrant surgery if unstable; leak often evolves into controlled fistula resolving over weeks/months |
| Urinary Tract | |
| CAUTI | Foley removal/exchange with initiation of antimicrobials; fungal CAUTI managed with catheter removal/exchange only |
| Pyelonephritis with obstruction | Ureteral stent or percutaneous nephrostomy for decompression; drain abscesses if postsurgical; remove/exchange infected stents |
| Skin and Soft Tissue | |
| Cellulitis | No procedures usually necessary |
| Cutaneous abscesses | Bedside incision and drainage (consider utilizing ultrasound guidance); operative drainage if abscess large or comorbidities |
| Superficial SSIs | Consider selective suture/staple removal; drain purulence; assess for fascial dehiscence if copious drainage |
| NSTIs | Early and frequent operative debridement; multidisciplinary reconstruction; antifungals, if needed |
| Infected thrombophlebitis | Elevation, compresses; surgical drainage with possible vein excision if suppurative |
| Diabetic foot infections | Targeted incision and drainage; may require partial/complete amputation; guillotine amputation for unstable patients; cryoamputation as salvage in unstable patients |
| Sacral decubitus ulcers | Bedside or OR debridement; diverting colostomy in severe cases; rotational flaps for reconstruction |
| Indwelling Devices | |
| CLABSI | Line removal; resite line if still clinically necessary; cautious salvage in ports/tunneled lines with antibiotics |
| Peritoneal dialysis catheter infection | Catheter removal if persistent infection, fungal/mycobacterial etiology, or feculent drainage; surgical exploration if perforation suspected |
| Gastric feeding tube complications | Early tube dislodgement may require abdominal exploration, gastric repair, and resiting via Stamm gastrostomy if peritonitis present |
| Infected orthopedic hardware/prosthetic joint infections | Multiple surgical options including wound/bone debridement, antibiotic bead placement, hardware removal ± delayed reconstruction, or even amputation |
| Miscellaneous | |
| Septic arthritis | Joint needle aspiration, arthroscopy, or open surgical drainage |
| Acute bacterial suppurative parotitis | ENT consult if no improvement in 48 hours; may necessitate surgical drainage; be cognizant of possible emergency airway if airway compromise develops |
| Sinusitis | ENT drainage in severe cases |
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree





